Cover Image
市場調查報告書

皮膚科處方藥的全球市場

World Prescription Dermatological Drugs Market, 10th Edition (Antiacne & Rosacea, Antiaging & Photodamage, Dermatitis & Seborrhea, Antifungal, Hair Loss & Hair Removal, Hyperpigmentation/Melasma & Depigmenting, Psoriasis and Skin Cancer Drug Market)

出版商 Kalorama Information 商品編碼 233324
出版日期 內容資訊 英文 414 Pages
訂單完成後即時交付
價格
Back to Top
皮膚科處方藥的全球市場 World Prescription Dermatological Drugs Market, 10th Edition (Antiacne & Rosacea, Antiaging & Photodamage, Dermatitis & Seborrhea, Antifungal, Hair Loss & Hair Removal, Hyperpigmentation/Melasma & Depigmenting, Psoriasis and Skin Cancer Drug Market)
出版日期: 2017年06月14日 內容資訊: 英文 414 Pages
簡介

本報告涵括全球皮膚科處方藥市場,提供抗粉刺,抗老化,皮膚炎,掉頭髮,乾癬,皮膚癌,肝斑,及脂漏性皮膚炎等,各種皮膚疾病所用之治療處方藥詳細分析,彙整各自的市場規模與研究開發趨勢,未來的預測,再加上主要的市場參與企業簡介等資訊。

第1章 摘要整理

第2章 簡介

  • 皮膚的結構與機能
    • 表皮
    • 真皮
    • 皮下組織
    • 表皮附件
  • 皮膚功能
  • 老化對皮膚的影響
  • 皮膚病理和治療
  • 藥物動力學
    • 藥物吸收
    • 分配
    • 生物有效性 (生物利用性)
  • 藥物輸送手法
  • 皮膚疾病的人口統計資料,發病率,及罹患率

第3章 課題與趨勢

  • 患者的適合性
  • 美容皮膚科醫生
  • 防曬油的利用
  • 黑色素瘤存活率低
  • 室內曬黑的問題
  • PHOSPHATIDYLGLYCEROL和PSORIASIS
  • 新的填充材選擇
  • 消費者迷信
  • 乾癬的遺傳性關聯
  • 生物學的皮膚科學
  • 處方藥改列成藥
  • 藥用化妝品
  • 遠隔皮膚科學
  • 給付問題
  • 市場微創治療朝向
  • MEDI-SPAS
  • 法規的影響:美國·全球
  • 健康保險計劃·治療費的影響
  • 競爭的影響因素:市場·治療模式的影響
  • 雷射治療
  • 窄頻UVB
  • 光線動態的療法
  • PYCR1遺傳基因
  • 信用卡條件的變化
  • 患者保護排列醫療費負擔合理化法 (PPACA)
  • Thermage
  • BRAF遺傳基因
  • 新的口服藥和粉刺的研究
  • 皮膚治療用合成脂質
  • 藥物輸送的重要性
  • 產業綜合

第4章 抗粉刺及酒糟處方藥

  • 疾病概要
  • 產品概要
    • 過氧化苯甲醯
    • 類視色素
    • 抗生素
    • 口服避孕藥
  • 研究開發
  • 市場規模與成長
    • 全球市場
    • 各地區市場
  • 市場未來
  • 競爭分析

第5章 抗老化及光損傷處方藥

  • 概要
  • 產品概要
    • 去角質
    • 保濕
    • 維甲酸
    • 防曬油
    • 肉毒桿菌·填充劑
  • 研究開發
  • 市場規模與成長
    • 全球市場
    • 各地區市場
  • 市場未來
  • 競爭分析

第6章 皮膚炎及脂漏性皮膚炎處方藥

  • 概要
  • 產品概要
    • 局部皮質類固醇藥
    • 全身皮質類固醇藥
    • 其他的產品
  • 研究開發
  • 市場規模與成長
    • 全球市場
    • 各地區市場
  • 市場未來
  • 競爭分析

第7章 抗真菌處方藥

  • 概要
  • 產品概要
    • 全身處方藥
    • 局部處方藥
  • 研究開發
  • 市場規模與成長
    • 全球市場:各類型
    • 各地區市場
  • 市場未來
  • 競爭分析

第8章 掉頭髮及脫毛處方藥

  • 概要
  • 產品概要
    • 抗雄激素
    • 雄激素抑制劑
    • 其他的治療藥物
  • 研究開發
  • 市場規模與成長
  • 全球市場
  • 各地區市場
  • 市場未來
  • 競爭分析

第9章 高色素沉著及肝斑處方藥

  • 概要
  • 產品概要
  • 市場規模與成長
  • 研究開發
  • 全球市場
  • 各地區市場
  • 市場未來
  • 競爭分析

第10章 乾癬處方藥

  • 概要
  • 產品概要
    • 主要的局部乾癬產品
    • 主要的全身乾癬製劑
    • 光線療法
    • 生技藥品
  • 研究開發
  • 市場規模與成長
  • 全球市場
  • 各地區市場
  • 市場未來
  • 競爭分析

第11章 皮膚癌處方藥

  • 概要
    • 非黑色素瘤皮膚癌
    • 惡性黑色素瘤
  • 產品概要
  • 研究開發
  • 市場規模與成長
  • 全球市場
  • 各地區市場
  • 市場未來
  • 競爭分析

第12章 其他皮膚疾病治療藥

  • 概要
    • 抗病毒劑
    • 抗寄生蟲劑
  • 產品概要
    • 抗病毒劑
    • 抗寄生蟲劑
  • 其他皮膚相關產品
  • 研究開發
  • 市場規模與成長
    • 全球市場
  • 各地區市場
  • 市場未來
  • 競爭分析

第13章 全球市場的摘要

  • 概要
  • 市場規模及預測
  • 市場分析:各國
    • 美國
    • 歐洲
    • 日本
    • 其他
  • 市場與競爭分析

第14章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI15384768

World Prescription Dermatological Drugs Market, 10th Edition (Antiacne and Rosacea, Antiaging and Photodamage, Dermatitis and Seborrhea, Antifungal, Hair Loss and Hair Removal, Hyperpigmentation/Melasma and Depigmenting, Psoriasis, Skin Cancer, and Miscellaneous Skin Disorder Drug Market)

The field of dermatology is currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded. World Prescription Dermatological Drugs Market takes an inclusive look at many different areas of dermatology and prescription dermatology products. This area of medicine has blossomed due to an increase in skin cancer incidence, new exciting biologics for psoriasis, increased demand by baby boomers -both men and women - for antiaging products, consolidation within the industry, and strong late stage pipeline entities.

World Markets for Prescription Dermatology Product Segments

The report's market data provide multiple year forecasts for different product segments within the worldwide market for prescription dermatological drugs, including the following world markets:

  • Worldwide Market for Prescription Acne and Rosacea Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Antiaging and Photodamage Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by Type, 2016-2021
  • Worldwide Market for Prescription Antifungal Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Hair Loss and Hair Removal Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Psoriasis Drugs by Type, 2014-2021
  • Worldwide Market for Skin Cancer Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by Type, 2014-2021

Markets by Geographical Region

The worldwide opportunity for prescription dermatology products is dominated by several key markets, including the United States, Europe, Japan, and rest of world. Penetration within any of the prescription dermatological drugs segments is based on the incidence and prevalence in different regions. Level of demand may be based on any number of factors including epidemiology (i.e., skin color), economic conditions, reimbursement issues, and availability of generic products. The report provides the following prescription dermatology drug data points:

  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Australia, and Other ROW Prescription Acne and Rosacea Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Australia, and Other ROW Prescription Antiaging and Photodamage Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Australia, and Other ROW Dermatitis and Seborrhea Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Australia, and Other ROW Antifungal Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Russia, and Other ROW Hair Loss and Hair Removal Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, China, India, Brazil, Russia, and ROW Hyperpigmentation/Melasma and Depigmenting Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, China, India, Brazil, Australia, and ROW Psoriasis Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, China, India, Brazil, Australia, and ROW Skin Cancer Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, China, South Korea, Brazil, Russia, and ROW Miscellaneous Skin Disorder Drugs Market, 2016-2021

Issues and Trends

There are numerous issues that are shaping the direction of the field of dermatology. Advancements in technology and knowledge of the disease process are influencing the research and development efforts of the industry, along with the decisions of what products to pursue.

This is an exciting time in dermatology as there continues to be a shift in the understanding of the pathophysiology of many skin diseases. Some of the most exciting new developments in dermatology include:

  • New biologics and their uses in dermatology
  • Movement towards dispensing prescription dermatology agents in the office
  • Growth in platelet rich plasma

Competitive Analysis

Demand in the prescription dermatology products market will likely remain high due to the aging population and the quest for lifestyle treatments to meet the needs of aging baby boomers. There are a number of companies participating in the worldwide market for prescription dermatological drugs, ranging from large international pharmaceutical companies, small niche pharmaceutical companies, to generic companies both large and small. There is also competitive pressure in this market from over-the-counter (OTC) participants. However, even with the availability of OTC products, manufacturers of prescription products continue to do well in terms of revenues.

World Prescription Dermatological Drugs Market provides revenues and market share by supplier for 2016 by market segment. In addition corporate profiles of the following prescription dermatological drugs market competitors are provided:

  • AbbVie, Inc.
  • Allergan
  • Almirall, S.A.
  • Amgen, Inc.
  • Anacor Pharmaceuticals, Inc.
  • Astellas Pharma, Inc.
  • Basilea Pharmaceutica Ltd.
  • Bayer
  • Biofrontera AG
  • Bristol-Myers Squibb
  • Cipher Pharmaceuticals
  • Cutanea Life Sciences
  • Dermira, Inc.
  • Galderma S.A.
  • Genentech
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • LEO Pharma A/S
  • Maruho Co. Ltd.
  • Merck & Company
  • Merz Pharma GmbH & Co KGaA
  • Mylan N.V.
  • Novan, Inc.
  • Novartis Pharmaceuticals Corporation
  • Pfizer, Inc.
  • PharmaDerm
  • Sienna Biopharmaceuticals, Inc.
  • Sinclair Pharma Plc.
  • Stiefel
  • Valeant Pharmaceuticals International

Table of Contents

1: EXECUTIVE SUMMARY

  • INTRODUCTION
  • SCOPE AND METHODOLOGY
  • SIZE AND GROWTH OF THE MARKET
    • Table 1-1: The Worldwide Market for Prescription Dermatological Drugs 2014-2021
  • ISSUES AND TRENDS AFFECTING THE MARKET
  • COMPETITIVE OUTLOOK

2: INTRODUCTION AND OVERVIEW

  • STRUCTURE AND FUNCTION OF THE SKIN
    • Epidermis
    • Dermis
    • Subcutaneous Tissue
    • Epidermal Appendages
  • FUNCTIONS OF THE SKIN
  • EFFECTS OF AGING ON THE SKIN
  • DERMATOLOGICAL CONDITIONS AND TREATMENT
  • PHARMACOKINETICS
    • Drug Absorption
    • Distribution
    • Bioavailability
    • Drug Delivery Methods
      • Table 2-1: Common Bases for Topical Dermatological Medications
  • DEMOGRAPHICS OF SKIN DISORDERS, INCIDENCE AND PREVALENCE
    • Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions

3: ISSUES AND TRENDS

  • INTRODUCTION
  • NEW THERAPEUTIC ERA ON HORIZON FOR ATOPIC DERMATITIS
  • NEW GUIDELINES FOR ROSACEA TREATMENT
  • PATIENT COMPLIANCE
  • COSMETICS DERMATOLOGISTS
  • SUNSCREEN USE
  • MELANOMA SURVIVAL RATES FALTER
  • NEW MELANOMA STAGING SYSTEM
  • INDOOR TANNING ISSUE
  • PHOSPHATIDYLGLYCEROL AND PSORIASIS
  • NEW FILLER OPTIONS
  • CONSUMER CONFUSION
  • GENETIC LINK TO PSORIASIS
  • BIOLOGIC DERMATOLOGY
  • RX-TO-OTC SWITCHES
    • Table 3-1: Selected Dermatological Rx-to-OTC Switches
  • COSMECEUTICALS
    • Antioxidants
    • Polypeptides
  • TELEDERMATOLOGY
  • REIMBURSEMENT ISSUES
  • MARKET SHIFT TOWARDS LESS INVASIVE PROCEDURES
  • MEDI-SPAS
  • COMBINATION THERAPIES
  • COMPETITIVE, ECONOMIC, SOCIAL FORCES DRIVING MARKET DEMAND
    • Society's Obsession with Physical Appearance
    • Male Aesthetic Growth
  • REGULATORY INFLUENCES: US & INTERNATIONAL
    • International Authorities
    • U.S. FDA & Other Regulatory Agencies
  • EFFECTS OF HEALTH INSURANCE PROGRAMS & TREATMENT COSTS
  • COMPETITIVE INFLUENCES - IMPACT ON MARKET & TREATMENT MODALITIES
    • Facial Skin--Bio-Physiology
    • The "Gray Areas" of Medicine
  • LASER THERAPY
  • NARROWBAND ULTRAVIOLET B
  • PHOTODYNAMIC THERAPY
  • PYCR1 GENE
  • CHANGES IN CREDIT CARD TERMS
  • PATIENT PROTECTION AND AFFORDABLE CARE ACT
  • THERMAGE
  • BRAF GENE
  • NEW ORAL MEDICATIONS AND RESEARCH FOR ACNE
  • SYNTHETIC LIPIDS FOR SKIN HEALING
  • IMPORTANCE OF DRUG DELIVERY
  • PLATELET RICH PLASMA IN DERMATOLOGY
  • INDUSTRY CONSOLIDATION

4: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS

  • DESCRIPTION OF DISORDERS
  • PRODUCT DESCRIPTION
  • Benzoyl Peroxide
    • Table 4-1: Common Benzoyl Peroxide Formulations
  • Retinoids
    • Table 4-2: Common Retinoid Formulations
  • Antibiotics
    • Table 4-3: Common Topical Antibiotic Formulations
  • Oral Contraceptives
    • Table 4-4: Common Oral Contraceptive Formulations
  • RESEARCH AND DEVELOPMENT
    • Table 4-5: Prescription Acne, Actinic Keratosis and Rosacea Formulations in Development
  • MARKET SIZE AND GROWTH
  • Worldwide Market
    • Table 4-6: The Worldwide Market for Prescription Acne and Rosacea Drugs by Type, 2014-2021 (Benzoyl, Retinoids, Antibiotics, Other)
    • Figure 4-1: The Worldwide Market for Prescription Acne and Rosacea Drugs, Share by Type, 2016 (Antibiotics, Retinoids, Benzoyl, Others)
    • Figure 4-2: The Worldwide Market for Prescription Acne and Rosacea Drugs, Share by Type, 2021 (Antibiotics, Retinoids, Benzoyl, Others)
  • Markets by Geographical Region
    • Table 4-7: Market Size and Growth for US Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-8: Market Size and Growth for Europe Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-9: Market Size and Growth for Germany Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-10: Market Size and Growth for France Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-11: Market Size and Growth for UK Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-12: Market Size and Growth for Italy Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-13: Market Size and Growth for Spain Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-14: Market Size and Growth for Other European Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-15: Market Size and Growth for Japan Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-16: Market Size and Growth for ROW Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-17: Market Size and Growth for China Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-18: Market Size and Growth for India Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-19: Market Size and Growth for Brazil Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-20: Market Size and Growth for Australia Prescription Acne and Rosacea Market, 2016-2021
    • Table 4-21: Market Size and Growth for Other ROW Prescription Acne and Rosacea Market, 2016-2021
  • THE FUTURE OF THE MARKET
  • COMPETITIVE ANALYSIS
    • Table 4-22: Worldwide Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier, 2016
    • Figure 4-3: Worldwide Market for Prescription Antiacne and Rosacea Drugs, Market Share by Supplier (%), 2016

5: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS

  • OVERVIEW
  • PRODUCT DESCRIPTION
    • Keratolytics
      • Table 5-1: Common Prescription Keratolytic Formulations
    • Moisturizers
      • Table 5-2: Occlusive Moisturizers - Categories of Ingredients
      • Table 5-3: Common Prescription Moisturizers
    • Retinoids
      • Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
    • Sunscreens
      • Table 5-5: Common Prescription Sunscreens
    • Botox and Fillers
      • Table 5-6: Other Prescription Antiaging and Photodamage Products
  • RESEARCH AND DEVELOPMENT
    • Table 5-7: Prescription Antiaging and Photodamage Formulations in Development
  • MARKET FORECAST AND GROWTH
  • Worldwide Market
    • Table 5-8: The Worldwide Market for Prescription Antiaging and Photodamage Drugs by Type, 2014-2021 (Keratolytics, Moisturizers, Retinoids, Sun-screens, Botox & Fillers)
    • Figure 5-1: The Worldwide Market for Prescription Antiaging and Photodamage Drugs, % Share by Type, 2016 (Fillers, Sunscreen, Retinoids, Moisturizer, Kerolytics)
    • Figure 5-2: The Worldwide Market for Prescription Antiaging and Photodamage Drugs, % Share by Type, 2021 (Fillers, Sunscreen, Retinoids, Moisturizer, Kerolytics)
  • Markets by Geographical Region
    • Table 5-9: Market Size and Growth for US Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-10: Market Size and Growth for Europe Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-11: Market Size and Growth for Germany Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-12: Market Size and Growth for France Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-13: Market Size and Growth for UK Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-14: Market Size and Growth for Italy Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-15: Market Size and Growth for Spain Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-16: Market Size and Growth for Other European Regions, Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-17: Market Size and Growth for Japan Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-18: Market Size and Growth for Rest of World Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-19: Market Size and Growth for China Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-20: Market Size and Growth for India Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-21: Market Size and Growth for Brazil Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-22: Market Size and Growth for Australia Prescription Antiaging and Photodamage Market, 2016-2021
    • Table 5-23: Market Size and Growth for Rest of World Prescription Antiaging and Photodamage Market, 2016-2021
    • Figure 5-3: The Worldwide Prescription Antiaging and Photodamage Market by Region (US, Europe, Japan, ROW), 2016 (%)
    • Figure 5-4: The Worldwide Prescription Antiaging and Photodamage Market by Region (US, Europe, Japan, ROW), 2021 (%)
  • FUTURE OF THE MARKET
  • COMPETITIVE ANALYSIS
    • Table 5-24: Worldwide Market for Prescription Antiaging and Photodamage Drugs, Revenues and Market Share by Supplier, 2016
    • Figure 5-5: Worldwide Market for Prescription Antiaging and Photodamage Drugs, Percent Market Share by Supplier (%), 2016

6: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS

  • OVERVIEW
  • DESCRIPTION OF PRODUCTS
  • Topical Corticosteroids
    • Table 6-1: Common Prescription Topical Corticosteroid Preparations
  • Systemic Corticosteroids
    • Table 6-2: Common Prescription Systemic Corticosteroids
  • Other Products
    • Table 6-3: Prescription Other Dermatitis Formulations
  • RESEARCH AND DEVELOPMENT
    • Table 6-4: Prescription Dermatitis Formulations in Development
  • MARKET FORECAST AND GROWTH
  • Worldwide Market by Type
    • Table 6-5: The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by Type, 2016-2021 (Topical, Systemic, Other)
    • Figure 6-1: The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, % Share by Type, 2016 (Topical, Systemic, Other)
    • Figure 6-2: The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, % Share by Type, 2021 (Topical, Systemic, Other)
  • Markets by Geographical Region
    • Table 6-6: Market Size and Growth for US Market for Prescription Dermatitis and Seborrhea Drugs, 2016-2021
    • Table 6-7: Market Size and Growth for Europe Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-8: Market Size and Growth for France Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-9: Market Size and Growth for Italy Prescription Dermatitis and Seborrhea Market, 2016-2021 .. 156
    • Table 6-10: Market Size and Growth for Germany Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-11: Market Size and Growth for Spain Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-12: Market Size and Growth for UK Prescription Dermatitis and Seborrhea Market, 2016-2021 .. 157
    • Table 6-13: Market Size and Growth for Other European Region, Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-14: Market Size and Growth for Japan Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-15: Market Size and Growth for Rest of World Market Prescription Dermatitis and Seborrhea, 2016-2021
    • Table 6-16: Market Size and Growth for China Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-17: Market Size and Growth for India Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-18: Market Size and Growth for Brazil Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-19: Market Size and Growth for Australia Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Table 6-20: Market Size and Growth for Rest of World Prescription Dermatitis and Seborrhea Market, 2016-2021
    • Figure 6-3: The Worldwide Prescription Dermatitis and Seborrhea Market by Region (US, Europe, Japan ROW), 2016 (%)
    • Figure 6-4: The Worldwide Prescription Dermatitis and Seborrhea Market by Region (US, Europe, Japan, ROW), 2021 (%)
  • FUTURE OF THE MARKET
  • COMPETITIVE ANALYSIS
    • Table 6-21: Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, Revenues and Market Share by Supplier, 2016
    • Figure 6-5: Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, Percent Market Share by Supplier, 2016

7: PRESCRIPTION ANTIFUNGAL DRUGS

  • OVERVIEW
  • PRODUCT DESCRIPTION
    • Systemic Formulations
    • Topical Formulations
    • Allylamines and Benzylamines
    • Other Topical Formulations
    • Novel Products
  • RESEARCH AND DEVELOPMENT
    • Table 7-1: Prescription Antifungal Formulations in Development
  • MARKET SIZE AND GROWTH
    • Worldwide Market by Type
      • Table 7-2: The Worldwide Market for Prescription Antifungal Drugs by Type, 2014-2021 (Topical, Systemic)
      • Figure 7-1: The Worldwide Market for Prescription Antifungal Drugs by Type (%), 2016 (Systemic, Topical)
      • Figure 7-2: The Worldwide Market for Prescription Antifungal Drugs by Type (%), 2021 (Systemic, Topical)
    • Markets by Geographical Region
      • Table7-3: Market Size and Growth for US Prescription Antifungal Drug Market, 2016-2021
      • Table 7-4: Market Size and Growth for Europe Antifungal Drug Market, 2016-2021
      • Table 7-5: Market Size and Growth for Germany Antifungal Drug Market, 2016-2021
      • Table 7-6: Market Size and Growth for France Antifungal Drug Market, 2016-2021
      • Table 7-7: Market Size and Growth for UK Antifungal Drug Market, 2016-2021
      • Table 7-8: Market Size and Growth for Italy Antifungal Drug Market, 2016-2021
      • Table 7-9: Market Size and Growth for Spain Antifungal Drug Market, 2016-2021
      • Table 7-10: Market Size and Growth for Other European Regions Antifungal Drug Market, 2016-2021
      • Table 7-11: Market Size and Growth for Japan Antifungal Drug Market, 2016-2021
      • Table 7-12: Market Size and Growth for ROW Antifungal Drug Market, 2016-2021
      • Table 7-13: Market Size and Growth for China Antifungal Drug Market, 2016-2021
      • Table 7-14: Market Size and Growth for India Antifungal Drug Market, 2016-2021
      • Table 7-15: Market Size and Growth for Brazil Antifungal Drug Market, 2016-2021
      • Table 7-16: Market Size and Growth for Australia Antifungal Drug Market, 2016-2021
      • Table 7-17: Market Size and Growth for Rest of World Antifungal Drug Market, 2016-2021
      • Figure 7-3: The Worldwide Antifungal Drug Market by Region (US, Europe, Japan, ROW), 2016 (%)
      • Figure 7-4: The Worldwide Antifungal Drug Market by Region (US, Europe, Japan, ROW), 2021 (%)
  • FUTURE OF THE MARKET
  • COMPETITIVE ANALYSIS
    • Table 7-18: Worldwide Market for Prescription Antifungal Drug Revenues and Market Share by Supplier, 2016
    • The Worldwide Market for Prescription Dermatological Drugs
    • June viii 2017 © Kalorama Information
    • Figure 7-5: Worldwide Market for Prescription Antifungal Drug Revenues and Market Share by Supplier (%), 2016

8: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS

  • OVERVIEW
  • PRODUCT DESCRIPTION
  • Antiandrogens
  • Androgen Inhibitors
    • Other Treatments
      • Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
  • RESEARCH AND DEVELOPMENT
    • Table 8-2: Prescription Hair Loss and Hair Removal Formulations in Development
  • MARKET FORECAST AND GROWTH
    • Worldwide Market by Type
      • Table 8-3: The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs by Type, 2014-2021 (Antiandrogens, Androgen Inhibitors, Others)
      • Figure 8-1: The Worldwide Prescription Hair Loss and Hair Removal Drug Market Share by Type (%), 2016 (Androgen Inhibitors, Antiandrogens, Others)
      • Figure 8-2: The Worldwide Prescription Hair Loss and Hair Removal Drug Market Share by Type (%), 2021 (Androgen Inhibitors, Antiandrogens, Others)
    • Markets by Geographical Region
      • Table 8-4: Market Size and Growth for US Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-5: Market Size and Growth for Europe Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-6: Market Size and Growth for the Germany Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-7: Market Size and Growth for the France Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-8: Market Size and Growth for the UK Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-9: Market Size and Growth for the Italy Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-10: Market Size and Growth for the Spain Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-11: Market Size and Growth for the Other European Regions, Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-12: Market Size and Growth for the Japan Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-13: Market Size and Growth for the Rest of World Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-14: Market Size and Growth for the China Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-15: Market Size and Growth for the India Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-16: Market Size and Growth for the Brazil Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-17: Market Size and Growth for the Russia Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Table 8-18: Market Size and Growth for the Rest of World Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
      • Figure 8-3: The Worldwide Prescription Hair Loss and Hair Removal Drug Market by Region (US, Europe, Japan, ROW), 2016 (%)
      • Figure 8-4: The Worldwide Prescription Hair Loss and Hair Removal Drug Market by Region (US, Europe, Asia/ROW), 2021 (%)
  • FUTURE OF THE MARKET
  • COMPETITIVE ANALYSIS
    • Table 8-19: Worldwide Market for Prescription Hair Loss and Hair Removal Revenues and Market Share by Supplier, 2016
    • Figure 8-5: Worldwide Market for Prescription Hair Loss and Hair Removal Drug Revenues and Market Share by Supplier (%), 2016

9: PRESCRIPTION HYPERPIGMENTATION/MELASMA AND DEPIGMENTING DRUGS

  • OVERVIEW
  • PRODUCT DESCRIPTION
    • Table 9-1: Common Prescription Hyperpigmentation/Melasma
    • Table 9-2: Common Prescription Depigmenting Agents
  • RESEARCH AND DEVELOPMENT
    • Table 9-3: Prescription Hyperpigmentation/ Melasma/ Depigmenting Formulations in Development
  • MARKET FORECAST AND GROWTH
    • Worldwide Market
      • Table 9-4: The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs by Type, 2014-2021 (Hyperpigmentation/Melasma, Depigmenting)
      • Figure 9-1: The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs, Share by Type (%), 2016
      • Figure 9-2: The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs, Share by Type (%), 2021
    • Markets by Geographical Region
      • Table 9-5: Market Size and Growth for US Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-6: Market Size and Growth for Europe Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-7: Market Size and Growth for Germany Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-8: Market Size and Growth for France Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • The Worldwide Market for Prescription Dermatological Drugs
      • June x 2017 © Kalorama Information
      • Table 9-9: Market Size and Growth for UK Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-10: Market Size and Growth for Italy Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-11: Market Size and Growth for Spain Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-12: Market Size and Growth for Other European Regions Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-13: Market Size and Growth for Japan Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-14: Market Size and Growth for China Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-15: Market Size and Growth for India Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-16: Market Size and Growth for Brazil Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-17: Market Size and Growth for Russia Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Table 9-18: Market Size and Growth for ROW Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
      • Figure 9-3: The Worldwide Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market by Region (US, Europe, Japan, ROW), 2016 (%)
      • Figure 9-4: The Worldwide Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market by Region (US, Europe, Japan, ROW), 2021 (%)
  • FUTURE OF THE MARKET
  • COMPETITIVE ANALYSIS

10: PRESCRIPTION PSORIASIS DRUGS

  • OVERVIEW
  • PRODUCT DESCRIPTION
    • Selected Topical Psoriasis Products
    • Methoxsalen
    • Selected Systemic Psoriasis Preparations
      • Table 10-1: Selected Prescription Psoriasis Preparations
    • Light Therapy
    • Biologics
      • Table 10-2: Prescription Biologics for Psoriasis Treatment
    • Novel Products
  • RESEARCH AND DEVELOPMENT
    • Table 10-3: Prescription Psoriasis Formulations in Development
  • MARKET FORECAST AND GROWTH
    • Worldwide Market by Type
      • Table 10-4: The Worldwide Market for Prescription Psoriasis Drugs by Type, 2014-2021 (Topical, Systemic, Others)
      • Figure 10-1: The Worldwide Market for Prescription Psoriasis Drugs, Share by Type (%), 2016 (Topical, Systemic, Others)
      • Figure 10-2: The Worldwide Market for Prescription Psoriasis Drugs, Share by Type (%), 2021 (Topical, Systemic, Others)
    • Markets by Geographical Region
      • Table 10-5: Market Size and Growth for US Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-6: Market Size and Growth for Europe Prescription Psoriasis Drug Market, 2016-2021
      • Table10-7: Market Size and Growth for Germany Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-8: Market Size and Growth for France Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-9: Market Size and Growth for UK Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-10: Market Size and Growth for Italy Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-11: Market Size and Growth for Spain Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-12: Market Size and Growth for Other European Regions Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-13: Market Size and Growth for Japan Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-14: Market Size and Growth for India Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-15: Market Size and Growth for China Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-16: Market Size and Growth for Brazil Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-17: Market Size and Growth for Australia Prescription Psoriasis Drug Market, 2016-2021
      • Table 10-18: Market Size and Growth for ROW Prescription Psoriasis Drug Market, 2016-2021
      • Figure 10-3: The Worldwide Market for Prescription Psoriasis Drugs, Share by Region (US, Europe, Japan, ROW), 2016 (%)
      • Figure 10-4: The Worldwide Market for Prescription Psoriasis Drugs, Share by Region, (US, Europe, Japan, ROW), 2021 (%)
  • FUTURE OF THE MARKET
  • COMPETITIVE ANALYSIS
    • Table 10-19: Worldwide Market for Prescription Psoriasis Drugs, Revenues and Market Share by Supplier, 2016
    • Figure 10-5: Worldwide Market for Prescription Psoriasis Drugs, Percent Market Share by Supplier, 2016

11: PRESCRIPTION SKIN CANCER DRUGS

  • OVERVIEW
    • Nonmelanoma Skin Cancers
      • Table 11-1: Malignant Conditions of the Skin
    • Malignant Melanoma
  • PRODUCT DESCRIPTION
    • 5-Fluorouracil
    • Mechlorethamine/Nitrogen Mustard
    • Carmustine/BCNU (Topical)
    • Vinblastine (Intralesional) and Others
      • Table 11-2: Common Prescription Topical, Intralesional and Other Skin Cancer Agents
  • RESEARCH AND DEVELOPMENT
    • Table 11-3: Prescription Skin Cancer Preparations in Development
  • MARKET SIZE AND GROWTH
    • Worldwide Market
      • Table 11-4: Worldwide Market for Skin Cancer Drugs, 2014-2021
      • Markets by Geographical Region
      • Table 11-5: Market Size and Growth for US Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-6: Market Size and Growth for Europe Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-7: Market Size and Growth for Germany Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-8: Market Size and Growth for France Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-9: Market Size and Growth for UK Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-10: Market Size and Growth for Italy Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-11: Market Size and Growth for Spain Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-12: Market Size and Growth for Other European Regions Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-13: Market Size and Growth for Japan Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-14: Market Size and Growth for China Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-15: Market Size and Growth for India Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-16: Market Size and Growth for Brazil Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-17: Market Size and Growth for Australia Prescription Skin Cancer Drug Market, 2016-2021
      • Table 11-18: Market Size and Growth for ROW Prescription Skin Cancer Drug Market, 2016-2021
      • Figure 11-1: The Worldwide Skin Cancer Drug Market, Percent Market Share by Geographic Region, 2016 (US, Europe, Japan, ROW)
      • Figure 11-2: The Worldwide Skin Cancer Drug Market, Percent Market Share by Geographic Region, 2021 (US, Europe, Japan, ROW)
  • FUTURE OF THE MARKET
  • COMPETITIVE ANALYSIS
    • Table 11-19: Worldwide Market for Prescription Skin Cancer Drugs, Revenues and Market Share by Supplier, 2016
    • Figure 11-3: Worldwide Market for Prescription Skin Cancer Drugs, Market Share by Supplier, 2016

12: MISCELLANEOUS SKIN DISORDER DRUGS

  • OVERVIEW
    • Antivirals
    • Antiparasitics
    • Others
  • PRODUCT DESCRIPTION
    • Antivirals
    • Current Suppliers
      • Table 12-1: Common Prescription Dermatological Systemic and Topical Antiviral Formulations
    • Current Suppliers
      • Table 12-2: Common Prescription Topical Antiparasitic Formulations
  • OTHER SKIN RELATED PRODUCTS
    • Table 12-3: Common Prescription Other Skin Formulations
  • RESEARCH AND DEVELOPMENT
    • Table 12-4: Prescription Miscellaneous Skin Preparations in Development
  • MARKET SIZE AND GROWTH
    • Worldwide Market
      • Table 12-5: The Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by Type, 2014-2021 (Antiviral, Antiparasitic, Others)
    • Markets by Geographical Region
      • Table 12-6: Market Size and Growth for US Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-7: Market Size and Growth for Europe Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-8: Market Size and Growth for Germany Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-9: Market Size and Growth for France Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-10: Market Size and Growth for UK Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-11: Market Size and Growth for Italy Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-12: Market Size and Growth for Spain Prescription Miscellaneous Skin Disorder Market, 2016-2021
      • Table 12-13: Market Size and Growth for Other European Regions Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-14: Market Size and Growth for Japan Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-15: Market Size and Growth for China Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-16: Market Size and Growth for South Korea Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-17: Market Size and Growth for Brazil Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-18: Market Size and Growth for Russia Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Table 12-19: Market Size and Growth for ROW Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
      • Future of the Market
  • COMPETITIVE ANALYSIS

13: WORLD MARKET SUMMARY

  • OVERVIEW
  • MARKET SIZE AND GROWTH
    • Table 13-1: The Worldwide Market for Prescription Dermatological Drugs, 2014-2021
  • MARKET ANALYSIS BY GEOGRAPHICAL REGION
    • United States
      • Table 13-2: United States Prescription Dermatological Drug Market, 2016-2021
  • Europe
    • Table 13-3: Europe Prescription Dermatological Drug Market, 2016-2021
    • Table 13-4: Germany Prescription Dermatological Drug Market, 2016-2021
    • Table 13-5: France Prescription Dermatological Drug Market, 2016-2021
    • Table 13-6: UK Prescription Dermatological Drug Market, 2016-2021
    • Table 13-7: Italy Prescription Dermatological Drug Market, 2016-2021
    • Table 13-8: Spain Prescription Dermatological Drug Market, 2016-2021
    • Table 13-9: Other European Regions Prescription Dermatological Drug Market, 2016-2021
  • Japan
    • Table 13-10: Japan Prescription Dermatological Drug Market, 2016-2021
  • Rest of World
    • Table 13-11: ROW Prescription Dermatological Drug Market, 2016-2021
    • Table 13-12: China Prescription Dermatological Drug Market, 2016-2021
    • Table 13-13: India Prescription Dermatological Drug Market, 2016-2021
    • Table 13-14: Brazil Prescription Dermatological Drug Market, 2016-2021
    • Table 13-15: ROW Prescription Dermatological Drug Market, 2016-2021
  • MARKET AND COMPETITIVE ANALYSIS
    • Table 13-16: Worldwide Market for Prescription Dermatological Drugs, Revenues and Market Share by Supplier, 2016

14: CORPORATE PROFILES

  • ABBVIE, INC
    • Table 14-1: AbbVie Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-2: AbbVie, Inc. Revenues (2013-2016)
  • ALLERGAN
    • Table 14-3: Allergan Corporate Summary
  • Company Overview
  • Company Financials
  • Table 14-4: Allergan Revenues (2013-2016)
  • ALMIRALL, S.A.
    • Table 14-5: Almirall Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-6: Almirall Revenues (2013-2016)
  • AMGEN, INC
    • Table 14-7: Amgen Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-8: Amgen, Inc. Revenues (2013-2016)
  • ANACOR PHARMACEUTICALS, INC
    • Table 14-9: Anacor Pharmaceuticals, Inc. Corporate Summary
  • Company Overview
  • ASTELLAS PHARMA, INC
    • Table 14-10: Astellas Pharma, Inc. Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-11: Astellas Pharma, Inc. Revenues (2013-2016)
  • BASILEA PHARMACEUTICA LTD.
    • Table 14-12: Basilea Pharmaceutica Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-13: Basilea Pharmaceutica Revenues (2013-2016)
  • BAYER
    • Table 14-14: Bayer Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-15: Bayer Revenues (2013-2016)
  • BIOFRONTERA AG
    • Table 14-16: Biofrontera AG Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-17: Biofrontera Revenues (2013-2016)
  • BRISTOL-MYERS SQUIBB
    • Table 14-18: Bristol-Myers Squibb Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-19: Bristol-Meyers Squibb Revenues (2013-2016)
  • CIPHER PHARMACEUTICALS
    • Table 14-20: Cipher Pharmaceuticals Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-21: Cipher Revenues (2013-2016)
  • CUTANEA LIFE SCIENCES
    • Table 14-22: Cutanea Life Sciences Corporate Summary
  • Company Overview
  • DERMIRA, INC.
    • Table 14-23: Dermira Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-24: Dermira Revenues (2013-2016)
  • GALDERMA S.A.
    • Table 14-25: Galderma S.A Corporate Summary
  • Company Overview
  • GENENTECH
    • Table 14-26: Genentech Corporate Summary
  • Company Overview
  • GLAXOSMITHKLINE PLC
    • Table 14-27: GlaxoSmithKline Plc Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-28: GlaxoSmithKline Plc. Revenues (2013-2016)
  • JOHNSON & JOHNSON
    • Table 14-29: Johnson & Johnson Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-30: Johnson & Johnson Revenues (2013-2016)
  • LEO PHARMA A/S
    • Table 14-31: LEO Pharma Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-32: LEO Pharma Revenues (2013-2016)
  • MARUHO CO. LTD.
    • Table 14-33: Maruho Corporate Summary
  • Company Overview
  • MERCK & COMPANY
    • Table 14-34: Merck & Company Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-35: Merck & Company Revenues (2013-2016)
  • MERZ PHARMA GMBH & CO KGAA
    • Table 14-36: Merz Pharma Corporate Summary
  • Company Overview
  • MYLAN N.V.
    • Table 14-37: Mylan Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-38: Mylan Revenues (2013-2016)
  • NOVAN, INC
    • Table 14-39: Novan Corporate Summary
  • Company Overview
  • NOVARTIS PHARMACEUTICALS CORPORATION
    • Table 14-40: Novartis Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-41: Novartis Revenues (2013-2016)
  • PFIZER, INC.
    • Table 14-42: Pfizer Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-43: Pfizer Revenues (2013-2016)
  • PHARMADERM
    • Table 14-44: PharmaDerm Corporate Summary
  • Company Overview
  • SIENNA BIOPHARMACEUTICALS, INC.
    • Table 14-45: Sienna Biopharmaceuticals Corporate Summary
  • Company Overview
  • SINCLAIR PHARMA PLC.
    • Table 14-46: Sinclair Pharma Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-47: Sinclair Pharma Revenues (2013-2016)
  • STIEFEL
    • Table 14-48: Stiefel Corporate Summary
  • Company Overview
  • VALEANT PHARMACEUTICALS INTERNATIONAL
    • Table 14-49: Valeant Pharmaceuticals Corporate Summary
  • Company Overview
  • Company Financials
    • Table 14-50: Valeant Revenues (2013-2016)
Back to Top